Psilocybin Mushrooms for PTSD

Age: 18+

Sex: Any

Trial Phase: Phase 1

Sponsor: Sue Sisley

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will examine the safety and preliminary efficacy of psilocybin mushrooms to treat adults with PTSD. Up to 24 participants will take part in this study. Each participant will ingest psilocybin from dried mushrooms in a chocolate formulation.

Are You a Good Fit for This Trial?

This trial is for adults with PTSD who can safely ingest psilocybin mushrooms. Specific eligibility details are not provided, but typically participants must be in good health and meet diagnostic criteria for PTSD.

Inclusion Criteria

My kidney function is good.

My liver is functioning well, with enzymes not exceeding 1.5 times the upper limit.

Willing and able to provide signed informed consent and comply with study requirements

Exclusion Criteria

My blood pressure is not controlled by medication.

I have had a seizure recently.

I have had a stroke or a transient ischemic attack.

What Are the Treatments Tested in This Trial?

Interventions

• Organic Whole Psilocybin-Containing Mushrooms

Trial Overview The study is testing the safety and initial effectiveness of psilocybin mushrooms, taken as a chocolate formulation, to help treat symptoms of PTSD in up to 24 adults.

How Is the Trial Designed?

Group I: 30mg of psilocybin administered orally in a single dosing session Experimental Treatment 1 Intervention

Who Is Running the Clinical Trial?

Sue Sisley

Lead Sponsor

Scottsdale Research Institute

Collaborator